HIFs mediate adaptive metabolic responses and mitochondrial ROS production in breast cancer tumour stem cells (BCSCs), enhancing the CSC phenotype via ITGA6 and promoting ALKBH5 expression, which plays a critical role in tumour-initiating breast cancer cells16–18. This evidence concerns the gene ALKBH5 and neoplasm.